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To The Editor 
We read with interest the editorial by Dr Elias: “Deep brain stimulation and intraoperative MRI”. The 
use of electrophysiology, clinical testing and intraoperative MRI in DBS surgery on patients under 
local anesthesia is described as a “paradigm shift”.5 However, many European centers and, more 
recently, a few US centers have long moved past this particular milestone. The paradigm shift in 
functional neurosurgery is not simply the use of MRI to guide the surgical procedure. It is the use of 
stereotactic imaging to both guide and verify the DBS procedure. 
Appropriate stereotactic MRI sequences can localize intracranial structures directly in patients under 
general anesthesia (GA), without the need for intraoperative clinical testing or neurophysiological 
recording.18 The radiological anatomy enables direct targeting, confirms lead position and guides 
relocation if required. Moreover, systematic analysis of targeting errors permits development of 
strategies to improve surgical accuracy and precision during subsequent procedures, thus tending to 
minimize the number of brain penetrations.7 Audit of lead location and its correlation with long-term 
clinical outcome can also inform on targeting strategies to improve clinical outcome and minimize 
adverse effects secondary to stimulation.16,17 
The editorial rightly points out a major limitation of its accompanying study, the lack of clinical 
information and outcome data.4 However, other studies using a purely image-guided and image-
verified approach do provide clinical outcome data and are not cited by either article. The Montpellier 
group has published excellent long term results after MRI-verified pallidal DBS for dystonia under 
GA.3,8 The Bristol group presented clinical hemibody results 6-months after MRI-verified DBS for 
PD.13 UPDRS data 9-months following MRI-verified STN DBS under GA has also been published by 
the San Francisco group.15 The Phoenix group are currently collecting clinical outcomes data after 
employing an image-verified approach to DBS under GA.10 Yet another US center advertises the 
benefits of the MRI-verified technique under GA to patients via their website.20 
Our group at Queen Square, London, has performed MRI-guided and MRI-verified DBS without 
microelectrode recording (MER) since 2002. Clinical results after surgery under general anesthesia 
and comprehensive clinical results 1, 5 and 8 years after STN DBS surgery have been published, 
including UPDRS data, quality of life scores and neuropsychological evaluations.1,6,11 
DBS aims to improve quality of life; therefore, safety is an absolute priority. An MRI-guided and 
MRI-verified approach is associated with a significantly lower incidence of all types of intracranial 
hemorrhage, including those leading to death or disability - an observation readily explainable by the 
fewer brain penetrations required by this technique.19 
Additional benefits of the MRI-guided and MRI-verified approach include increased patient comfort 
and reduced anxiety as well as avoidance of complete levodopa withdrawal and consequently less 
confusion in the perioperative period. Moreover, significantly shorter operative times and cost 
ultimately allow more patients to access DBS therapy.9 During DBS surgery under GA, positive 
pressure ventilation increases intracranial pressure that, combined with meticulous entry planning on a 
gyrus and short “dura open” time, prevents brain slump. Consequently, CSF egress, pneumocephalus 
and brain shift are minimized.12 Conversely, and somewhat perversely, huge targeting errors of >5-10 
mm have been reported in patients undergoing MER during awake stereotactic surgery, presumably 
secondary to large amounts of pneumocephalus and brain shift.2,14 
The editorial suggestion that “a hybrid technique that emphasizes electrophysiology and intraoperative 
imaging may become the standard for stereotactic surgery” may instead negate many of the 
advantages of a purely MRI-guided and MRI-verified approach. Ultimately, individual neurosurgeons 
should decide which techniques to use when performing a procedure. However, many of the benefits 
of a paradigm shift towards MRI-Guided and MRI-Verified DBS surgery may never materialize if 
combined with traditional techniques. 
 
References 
1. Avilés-Olmos I, Kefalopoulou Z, Tripoliti E, Candelario J, Akram H, Martinez-Torres I, et al.: 
Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease 
using an MRI-guided and MRI-verified approach. Journal of Neurology, Neurosurgery & 
Psychiatry 85:1419–1425, 2014 
2. Bot M, van den Munckhof P, Bakay R, Sierens D, Stebbins G, Verhagen Metman L: Analysis 
of Stereotactic Accuracy in Patients Undergoing Deep Brain Stimulation Using Nexframe and 
the Leksell Frame. Stereotact Funct Neurosurg:316–325, 2015 
3. Cif L, Vasques X, Gonzalez V, Ravel P, Biolsi B, Collod-Beroud G, et al.: Long-term follow-
up of DYT1 dystonia patients treated by deep brain stimulation: An open-label study. Mov 
Disord 25:289–299, 2010 
4. Cui Z, Pan L, Song H, Xu X, Xu B, Yu X, et al.: Intraoperative MRI for optimizing electrode 
placement for deep brain stimulation of the subthalamic nucleus in Parkinson disease. Journal 
of Neurosurgery:1–8, 2015 
5. Elias WJ: Deep brain stimulation and intraoperative MRI. Journal of Neurosurgery:1–3, 2015 
6. Foltynie T, Zrinzo L, Martinez-Torres I, Tripoliti E, Petersen E, Holl E, et al.: MRI-guided 
STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. 
Journal of Neurology, Neurosurgery & Psychiatry 82:358–363, 2011 
7. Holl EM, Petersen EA, Foltynie T, Martinez-Torres I, Limousin P, Hariz MI, et al.: Improving 
Targeting in Image-Guided Frame-Based Deep Brain Stimulation. Neurosurgery 67:ons437–
ons447, 2010 
8. Maldonado IL, Roujeau T, Cif L, Gonzalez V, Fertit El H, Vasques X, et al.: Magnetic 
resonance-based deep brain stimulation technique: a series of 478 consecutive implanted 
electrodes with no perioperative intracerebral hemorrhage. Neurosurgery 65:196–201– 
discussion 201–2, 2009 
9. McClelland S: A cost analysis of intraoperative microelectrode recording during subthalamic 
stimulation for Parkinson's disease. Mov Disord 26:1422–1427, 2011 
10. Mirzadeh Z, Chapple K, Lambert M, Dhall R, Ponce FA: Validation of CT-MRI fusion for 
intraoperative assessment of stereotactic accuracy in DBS surgery. Mov Disord 29:1788–1795, 
2014 
11. Nakajima T, Zrinzo L, Foltynie T, Olmos IA, Taylor C, Hariz MI, et al.: MRI-guided 
subthalamic nucleus deep brain stimulation without microelectrode recording: can we dispense 
with surgery under local anaesthesia? Stereotact Funct Neurosurg 89:318–325, 2011 
12. Petersen EA, Holl EM, Martinez-Torres I, Foltynie T, Limousin P, Hariz MI, et al.: 
Minimizing Brain Shift in Stereotactic Functional Neurosurgery. Neurosurgery 67:ons213–
ons221, 2010 
13. Plaha P: Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic 
nucleus in improving contralateral parkinsonism. Brain 129:1732–1747, 2006 
14. Smeding HMM, Speelman JD, Koning-Haanstra M, Schuurman PR, Nijssen P, van Laar T, et 
al.: Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled 
study. Neurology 66:1830–1836, 2006 
15. Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS: Subthalamic nucleus deep 
brain stimulator placement using high-field interventional magnetic resonance imaging and a 
skull-mounted aiming device: technique and application accuracy. Journal of Neurosurgery 
112:479–490, 2010 
16. Tisch S, Zrinzo L, Limousin P, Bhatia KP, Quinn N, Ashkan K, et al.: Effect of electrode 
contact location on clinical efficacy of pallidal deep brain stimulation in primary generalised 
dystonia. Journal of Neurology, Neurosurgery & Psychiatry 78:1314–1319, 2007 
17. Tripoliti E, Zrinzo L, Martinez-Torres I, Frost E, Pinto S, Foltynie T, et al.: Effects of 
subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 
76:80–86, 2011 
18. Zrinzo L, Foltynie T, Limousin P, Hariz M: Image-verified deep brain stimulation reduces risk 
and cost with no apparent impact on efficacy. Mov Disord 27:1585–1586, 2012 
19. Zrinzo L, Foltynie T, Limousin P, Hariz MI: Reducing hemorrhagic complications in 
functional neurosurgery: a large case series and systematic literature review. Journal of 
Neurosurgery 116:84–94, 2012 
20. Available: http://www.clevelandclinic.org/lp/natl-parkinsons/index.html. Accessed 16 August 
2015 
 
